The most common combination of alterations in both APC and TP53 in our patients are in concordance with a previous study which involved European CRC patients (Smith et al., 2002) but contradicted with a report in Chinese CRCs (Cai Z.X. et al., 2014). Here, TP53 is linked to colorectal carcinoma.